Strength After Elbow Fractures in the Elderly
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Patient Reported Outcomes, Strength Test.
- Who it may be relevant to
- Registry conditions: Fracture;Elbow. Basic parameters: from 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Strength and Function After Non-operative Treatment of Displaced Olecranon Fractures in the Elderly: Implications of Standing UP From a Seat
Overview
Elderly patients strength and function, specifically the ability to rise from a seat after either operative or non operative treatment of an mayo type 2 olecranon fracture.
Detailed description
Elderly patients with an olecranon fracture will receive appropriate treatment as determined by the treating surgeon. Patients will then be assessed at 6 weeks, 6 months and 12 months post treatment. Assessments include, range of motion, patient reported outcomes and a strength test.
Interventions
- Other Patient Reported Outcomes
Satisfaction, Disabilities of the Shoulder, Arm and Hand - Other Strength Test
Handheld dynamometer to measure tricep extension
Primary outcome measures
- Extension Strength [Time frame: 12 Months]
Secondary outcome measures (4)
- Arc of Motion [Time frame: 12 months]
- Mayo Elbow Performance Index [Time frame: 12 Months]
- Disabilities of the Arm, Shoulder, and Hand [Time frame: 12 Months]
- Satisfaction Score [Time frame: 6 weeks, 6 months and 12 months]
Eligibility criteria
Inclusion criteria
- ≥65 years of age
- Mayo type II olecranon fracture
- Ambulatory (with or without the use of walking aides)
Exclusion criteria
- Additional injuries to the affected arm or contralateral arm
- Associated nerve injury
- Dementia or cognitive impairment that inhibits the collection of outcome measures
- Likely problems, in the judgement of the investigator, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged, patients without adequate support, etc.)
- Injury or previous deficit to the contralateral arm
- Currently enrolled in any other research study involving drugs or medical devices
- Open fractures
- Inability to provide informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Canada · 1 center
- Royal Columbian Hospital — New Westminster
Identifiers
NCT: NCT05135949 · 2020-147